Skip to main content
H

HEXIMA LIMITED. — Investor Relations & Filings

Ticker · HXL ISIN · AU0000111932 ASX Professional, scientific and technical activities
Filings indexed 244 across all filing types
Latest filing 2025-08-28 Regulatory Filings
Country AU Australia
Listing ASX HXL

About HEXIMA LIMITED.

https://hexima.com.au/

Hexima Limited focuses on the research and development of plant-derived proteins for human therapeutic applications. The company's primary development candidate is pezadeftide (HXM163), a proprietary plant defensin formulated as a topical treatment for onychomycosis, a fungal nail infection. Pezadeftide is engineered to penetrate the nail plate and target underlying fungal pathogens. The company's technology platform utilizes the natural defense mechanisms of plants to develop novel antimicrobial and antifungal treatments. Originally focused on agricultural biotechnology, the company transitioned to human health to address unmet needs in dermatology. Its activities involve the clinical evaluation of protein-based therapies designed to offer improved efficacy and safety profiles compared to existing antifungal treatments.

Recent filings

Filing Released Lang Actions
Appendix 4G 11 pages 246.3KB
Regulatory Filings
2025-08-28 English
Business Activity Statement & Appendix 4C - Jun-2025 Qtr 6 pages 1.1MB
Regulatory Filings
2025-07-30 English
Business Activity Statement & Appendix 4C - Mar-2025 Qtr 6 pages 1.1MB
Regulatory Filings
2025-04-29 English
Change of registry address notification 1 page 111.
Regulatory Filings
2025-04-13 English
Notification of cessation of securities - HXL 4 pages 14.8KB
Regulatory Filings
2025-04-02 English
Appendix 4D & Interim Financial Report 19 pages 891.5KB
Regulatory Filings
2025-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.